Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)

Completed · Phase 2/Phase 3

Conditions studied: Depression

In brief

The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.

Key facts

Study ID

NCT00018902

Run by

University of Pittsburgh

People needed

334

Starts

2001-01-01

Expected to finish

2007-03-01

Last updated by the study team

2014-03-12

Who can join

Age: 12 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California at Los Angeles — Los Angeles, California, United States
• Kaiser Permanente Center for Health Research — Portland, Oregon, United States
• Western Psychiatric Institute and Clinic of University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• Brown University — Providence, Rhode Island, United States
• University of Texas - Southwestern Medical Center — Dallas, Texas, United States
• University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.